Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-10-28 | Mersana Therapeutics, Inc. | Bala Mohan
(SVP, Chief Development Officer) |
S | Common Stock | D | 1884 | $1.90 - $1.90 | $3,579 |
| 2024-10-25 | Mersana Therapeutics, Inc. | Bala Mohan
(SVP, Chief Development Officer) |
M | Common Stock | A | 6250 | $0.00 - $0.00 | $0 |
| 2024-10-02 | Mersana Therapeutics, Inc. | DeSchuytner Brian
(SVP, COO & CFO) |
S | Common Stock | D | 13687 | $1.96 - $2.00 | $27,150 |
| 2024-10-01 | Mersana Therapeutics, Inc. | DeSchuytner Brian
(SVP, COO & CFO) |
M | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-10-02 | Mersana Therapeutics, Inc. | Carvajal Alejandra
(SVP, Chief Legal Officer) |
S | Common Stock | D | 13687 | $1.96 - $2.00 | $27,150 |
| 2024-10-01 | Mersana Therapeutics, Inc. | Carvajal Alejandra
(SVP, Chief Legal Officer) |
M | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-10-02 | Mersana Therapeutics, Inc. | Bala Mohan
(SVP, Chief Development Officer) |
S | Common Stock | D | 13687 | $1.96 - $2.00 | $27,150 |
| 2024-10-01 | Mersana Therapeutics, Inc. | Bala Mohan
(SVP, Chief Development Officer) |
M | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-10-02 | Mersana Therapeutics, Inc. | Mandelia Ashish
(VP, Chief Accounting Officer) |
S | Common Stock | D | 8216 | $1.96 - $2.00 | $16,297 |
| 2024-10-01 | Mersana Therapeutics, Inc. | Mandelia Ashish
(VP, Chief Accounting Officer) |
M | Common Stock | A | 30000 | $0.00 - $0.00 | $0 |
| 2024-10-02 | Mersana Therapeutics, Inc. | Lowinger Timothy B
(SVP, Chief Sci.&Tech. Officer) |
S | Common Stock | D | 13687 | $1.96 - $2.00 | $27,150 |
| 2024-10-01 | Mersana Therapeutics, Inc. | Lowinger Timothy B
(SVP, Chief Sci.&Tech. Officer) |
M | Common Stock | A | 50000 | $0.00 - $0.00 | $0 |
| 2024-09-12 | Mersana Therapeutics, Inc. | Huber Martin H. Jr.
(President, CEO) |
S | Common Stock | D | 50423 | $1.76 - $1.76 | $88,744 |
| 2024-09-11 | Mersana Therapeutics, Inc. | Huber Martin H. Jr.
(President, CEO) |
M | Common Stock | A | 166750 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |